a vaccine made from immune system cells collected from a patient with prostate cancer. the cells are treated in the laboratory with a growth factor attached to a protein found on prostate cancer cells. apc8015 injected into patients may stimulate t lymphocytes to kill tumor cells that express the prostate protein. also called provenge and sipuleucel-t.
![]()